# Symbio -- Specialized CRO for Dermatology, Aesthetics, Gastroenterology, and Inflammation Clinical Trials > Sitemap: https://symbioresearch.com/site-map/ Symbio is a therapeutically focused, full-service contract research organization (CRO) that delivers end-to-end Phase I-IV clinical trials and medical device studies in dermatology, aesthetics, gastroenterology, and inflammatory disease for drug and device sponsors worldwide. Unlike large generalist CROs, Symbio pairs profound therapeutic specialization with a responsive, consistent team (no handoffs, no turnover) and a strong network of specialty sites, which is why sponsors choose Symbio when they need faster startup and reliable enrollment in niche indications. The company has supported 650+ trials across 85+ indications, contributing to 70+ FDA approvals, with in-house teams for clinical operations, medical monitoring, regulatory affairs, medical writing, data management, biostatistics, and topical formulation development, and offices across North America, Europe, and Australia. ## Therapeutic Expertise - [Therapeutic Expertise -- Specialized CRO for Dermatology, Aesthetics, Gastroenterology, and Inflammation Trials](https://symbioresearch.com/therapeutic-expertise/): Overview of Symbio's focused therapeutic areas for drug and device sponsors who want a CRO that understands the unique patient populations, endpoints, and regulatory demands of specialty trials. Covers dermatology, aesthetics, gastroenterology, inflammatory disease, rare disease, and medical device studies across Phases I through IV. - [Dermatology Clinical Trials -- Full-Service Dermatology CRO for Phase I-IV Drug and Device Studies](https://symbioresearch.com/therapeutic-expertise/dermatology/): For sponsors seeking an experienced dermatology CRO, Symbio manages skin-condition trials from proof of concept through Phase IV, with 20+ years of focus and hundreds of dermatology trials behind dozens of FDA approvals. Ideal for atopic dermatitis, psoriasis, acne, rare skin disease, and other dermatological programs needing fast startup and dependable enrollment. - [Aesthetics Clinical Trials -- Specialized Aesthetics CRO for Toxin, Filler, and Device Studies](https://symbioresearch.com/therapeutic-expertise/aesthetics/): Symbio runs aesthetics trials for sponsors developing injectables, toxins, dermal fillers, and aesthetic devices, backed by a site network built for the specialized rating scales and photographic endpoints these studies require. A strong fit for sponsors who need an aesthetics CRO with the right investigators and rapid patient recruitment. - [Gastroenterology Clinical Trials -- Specialized GI CRO for Inflammatory and Digestive Disease Studies](https://symbioresearch.com/therapeutic-expertise/gastroenterology/): Symbio supports gastroenterology and gastrointestinal disease trials, applying clinical trial expertise translated from its dermatology and inflammation work to GI indications. Built for sponsors who want a niche CRO partner for digestive and inflammatory bowel disease programs. - [Inflammation Clinical Trials -- Specialized CRO for Inflammatory Disease Drug Development](https://symbioresearch.com/therapeutic-expertise/inflammation/): Symbio conducts inflammatory disease trials across dermatology-adjacent and systemic conditions, helping sponsors advance biologics and other therapies through complex immunology and inflammation endpoints. For sponsors seeking an inflammation CRO with profound therapeutic understanding and a proven site network. ## CRO Services - [CRO Services -- End-to-End Clinical Trial Management for Specialty Drug and Device Development](https://symbioresearch.com/services/): Full-service CRO offering for sponsors who want all core clinical trial functions managed in-house rather than subcontracted, including clinical trial project management, site feasibility and startup, clinical monitoring, medical monitoring, regulatory affairs, medical writing, clinical data management, and biostatistics. Available as a full-service engagement or as a functional service provider (FSP), a model where Symbio staffs specific functions within a sponsor's own team. - [Symbio's Networks -- Global Clinical Trial Site Network for Fast Startup and Enrollment](https://symbioresearch.com/services/symbios-networks/): Symbio's specialty site network spans North America, Europe, and Australia, giving sponsors access to high-performing dermatology, aesthetics, gastroenterology, and inflammation sites for quicker site selection, startup roughly twice as fast as industry norms, screen fail rates under 8%, and about 70% patient retention. For sponsors who need dependable global reach and rapid recruitment in niche indications. - [Topical Formulation Development -- In-House Topical and Dermatological Formulation CRO Services](https://symbioresearch.com/services/topical-formulation/): Symbio's dedicated laboratory and manufacturing facility develops topical formulations and provides small-scale manufacturing, packaging, and labeling for dermatological and topical drug products. A strong fit for sponsors who want early formulation development and clinical supply managed by the same partner running the trial, reducing handoffs and timelines. ## Resources and Insights - [Resources -- White Papers, Case Studies, and Articles on Specialty Clinical Trial Design](https://symbioresearch.com/resources/): Central library of Symbio's clinical research insights for sponsors and study teams, covering trial design, regulatory strategy, recruitment, and therapeutic trends across dermatology, aesthetics, gastroenterology, and inflammation. - [Case Study: Atopic Dermatitis -- Recruitment and Retention in a Dermatology Trial](https://symbioresearch.com/resources/atopic-dermatitis/): A detailed look at how Symbio drove patient recruitment and retention in an atopic dermatitis study, useful for sponsors evaluating a CRO's real-world performance in competitive dermatology enrollment. - [Article: Translating Clinical Trial Expertise from Dermatology to Gastrointestinal Disorders](https://symbioresearch.com/resources/translating-clinical-trial-expertise-from-dermatology-to-gastrointestinal-disorders/): Explains how methods and lessons from dermatology trials transfer to gastroenterology and GI disease research, for sponsors weighing a specialized CRO's ability to work across related therapeutic areas. - [Case Study: Global Phase III Psoriasis Trial -- Fast Recruitment and High Retention](https://symbioresearch.com/resources/how-symbio-delivered-fast-recruitment-high-retention-in-a-global-phase-3-psoriasis-trial/): Documents how Symbio delivered rapid recruitment and strong retention in a global Phase III psoriasis program, relevant to sponsors planning large multi-region dermatology or inflammation trials. - [Case Study: Aesthetics Trials Demand a Specialized CRO and Strong Site Network](https://symbioresearch.com/resources/aesthetics-trials-demand-a-specialized-cro/): Makes the case for why aesthetics studies need a dedicated CRO and investigator network, with examples of how Symbio's approach benefits sponsors of toxin, filler, and aesthetic device trials. - [Fact Sheet: Enhance Your Dermatology Clinical Trials With Symbio](https://symbioresearch.com/resources/enhance-your-dermatology-clinical-trials-with-symbio/): A quick-reference overview of Symbio's dermatology CRO capabilities and performance metrics, for sponsors comparing specialized dermatology CROs at a glance. - [White Paper: Navigating Phase II and Phase III Clinical Trials in the US and EU](https://symbioresearch.com/resources/navigating-phase-ii-and-phase-iii-clinical-trials/): A practical guide to running Phase II and Phase III trials across US and European regulatory environments, covering trends, challenges, and best practices for sponsors planning transatlantic development programs. - [White Paper: FDA and EMA Overview -- Cross-Disease Innovation](https://symbioresearch.com/resources/fda-and-ema-overview-cross-disease-innovation/): Compares FDA and EMA regulatory considerations and highlights innovation across disease areas, for sponsors coordinating global submissions and cross-region clinical strategy. - [White Paper: Design of Experiment and Statistical Analysis in Dermatology and Aesthetic Trials](https://symbioresearch.com/resources/design-of-experiment-and-statistical-analysis-in-dermatology-and-aesthetic-trials/): Best practices for study design and biostatistics in dermatology and aesthetics research, aimed at sponsors and biostatisticians optimizing endpoints and analysis plans in specialty trials. - [Article: Translating Clinical Trial Expertise Across Therapeutic Areas](https://symbioresearch.com/resources/translating-clinical-trial-expertise/): Discusses how clinical trial knowledge transfers between related therapeutic areas, supporting sponsors who want a CRO with adaptable, cross-disease experience. - [White Paper: Rare Skin Diseases -- Design of Experiment and Statistical Analysis](https://symbioresearch.com/resources/rare-skin-diseases/): Focused guidance on designing and analyzing trials for rare dermatological conditions, where small patient populations demand careful study design, for sponsors developing rare skin disease therapies. - [White Paper: Prurigo Nodularis -- Clinical Research Considerations](https://symbioresearch.com/resources/prurigo-nodularis/): An in-depth look at prurigo nodularis and what its disease characteristics mean for clinical trial design, for sponsors developing treatments for this chronic inflammatory skin condition. - [Article: Trends in Atopic Dermatitis -- Treatments and Trial Design](https://symbioresearch.com/resources/trends-in-atopic-dermatitis-treatments-and-trial-design/): Explores current atopic dermatitis treatment trends and their implications for trial design, for sponsors developing new therapies in this fast-moving dermatology space. ## About Symbio - [About Symbio -- Niche, Full-Service CRO Specializing in Dermatology and Adjacent Therapeutic Areas](https://symbioresearch.com/about/): Company background on Symbio as a client-focused specialty CRO, including its formation through the merger of Symbio, Dow Development Laboratories, and Proinnovera into one of the world's largest dermatology-focused CROs. For sponsors who want to understand Symbio's history, scale, and therapeutic focus before partnering. - [Our Team -- Experienced Clinical Research Leadership and Specialists](https://symbioresearch.com/about/our-team/): Introduces the specialists behind Symbio's trials, including medical monitors who are qualified M.D.s with 10+ years of experience and clinical research associates averaging 8+ years in the field. For sponsors evaluating the depth and stability of a CRO's in-house team. - [Careers -- Clinical Research Jobs at a Specialized Global CRO](https://symbioresearch.com/careers/): Career opportunities for clinical research professionals who want to join a therapeutically focused CRO with long-tenured teams and global reach. - [News and Events -- Symbio Announcements, Conferences, and Industry Updates](https://symbioresearch.com/news-events/): Latest company news, conference appearances, and industry updates from Symbio, including expansion announcements and new resources for sponsors and investigators. ## Connect - [Contact Us -- Partner With Symbio for Your Specialty Clinical Trial](https://symbioresearch.com/contact-us/): Get in touch to discuss a dermatology, aesthetics, gastroenterology, or inflammation trial and request a proposal or capabilities discussion with Symbio's team. - [LinkedIn](https://www.linkedin.com/company/symbioresearch/): Follow Symbio on LinkedIn for company updates and clinical research insights. - [X](https://x.com/SymbioResearch): Follow Symbio on X for news and announcements. ## Policies - [Site Map](https://symbioresearch.com/site-map/): Full index of Symbio's website pages. - [Legal Notice](https://symbioresearch.com/legal-notice/): Legal information governing use of Symbio's website and services. - [Accessibility Statement](https://symbioresearch.com/accessibility-statement/): Symbio's commitment to and approach to website accessibility. - [Privacy Policy](https://symbioresearch.com/privacy-policy/): How Symbio collects, uses, and protects personal data. - [Code of Conduct](https://symbioresearch.com/code-of-conduct/): Ethical standards guiding Symbio's conduct and operations.